project id: TCGA-UCEC; case submitter id: TCGA-AJ-A23O; source center: 23; state: released; concentration: 0.17; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.7; rna integrity number: 7.1; spectrophotometer method: UV Spec; age at index: 69; days to birth: -25433; days to death: 312; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1941; age at diagnosis: 25433; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 60.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus uteri; synchronous malignancy: No; tissue or organ of origin: Fundus uteri; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 165; initial weight: 120.0; oct embedded: false; preservation method: Unknown; sample id: b8e857f7-25b5-481d-b374-075138925fb8; sample submitter id: TCGA-AJ-A23O-01A; portion id: c154364f-593f-444a-a485-1058043f9cec; portion submitter id: TCGA-AJ-A23O-01A-11; slide id: 972cfefd-a013-47c2-a77e-661421b5059d; slide submitter id: TCGA-AJ-A23O-01A-01-TSA; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;